Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
396.17
0.00 (0.00%)
Aug 26, 2026, 4:00 PM EDT - Market closed

Bio-Rad Laboratories Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
222.4759.9-1,844-637.3-3,6284,254
Depreciation & Amortization
168.7165.4151.6145.9137.3137.6
Loss (Gain) From Sale of Assets
----2.5-1.4-
Asset Writedown & Restructuring Costs
172.8172.829.5---
Loss (Gain) From Sale of Investments
-248-894.42,6571,2525,206-4,925
Stock-Based Compensation
60.35862.361.360.951.2
Other Operating Activities
-6.6-3.320-1222.18.74
Change in Accounts Receivable
21.319.616.211.4-87.4-20.4
Change in Inventory
27.568.98.5-46.3-158.846.1
Change in Accounts Payable
-8.5-0.1-40.9-51.8-94.269.9
Change in Income Taxes
51.71.524.1-21.3-1.2-28.8
Change in Other Net Operating Assets
-1512-1.9-2.2-26.8-8.6
Operating Cash Flow
492.6532.2455.2374.9194.4669.5
Operating Cash Flow Growth
-7.79%16.92%21.42%92.85%-70.96%14.44%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-139.5-157.6-165.6-156.7-112.8-133.75
Sale of Property, Plant & Equipment
-0.10.10.20.20.05
Cash Acquisitions
-0.7-218.5---100.7-125.52
Divestitures
---2.51.4-
Sale (Purchase) of Intangibles
---23.4--1.5-
Investment in Securities
-96.9186.328.7174.2-994.2-84.73
Investing Cash Flow
-237.1-189.7-160.220.2-1,208-797.38

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----1,186-
Long-Term Debt Repaid
--0.5-0.4-0.5-0.5-3.02
Net Debt Issued (Repaid)
-0.5-0.5-0.4-0.51,186-3.02
Issuance of Common Stock
14.915.819.218.517.620.63
Repurchase of Common Stock
-135.7-298.5-207-443.6-229.7-72.48
Other Financing Activities
0.5--30.6---0.56
Financing Cash Flow
-120.8-283.2-218.8-425.6973.6-55.43

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
12.4-16.99.20.43-12.64
Miscellaneous Cash Flow Adjustments
------0.04
Net Cash Flow
147.142.485.4-30.1-36.6-195.98

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
353.1374.6289.6218.281.6535.75
Free Cash Flow Growth
-4.83%29.35%32.72%167.40%-84.77%12.45%
Free Cash Flow Margin
13.64%14.50%11.28%8.17%2.91%18.33%
Free Cash Flow Per Share
13.1213.7310.267.472.7417.74
Levered Free Cash Flow
283.19256.55193.49124.282.86485.98
Unlevered Free Cash Flow
313.69287.18224.05155.1626.68486.95

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
29.861.699.4129.6158.3134.68
Change in Working Capital
121.6272.4-620.8-432.8-1,6101,143
SEC Filings: 10-K · 10-Q